Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderGoing beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical reviewLithium in the treatment of bipolar disorder: pharmacology and pharmacogeneticsDual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsLithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsLithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression.Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era.Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with major depressive disorder--the EMC trialCurrent nosology of treatment resistant depression: a controversy resistant to revisionChronic and treatment resistant depression: diagnosis and stepwise therapy.Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment.Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority TrialPharmacologic approaches to treatment resistant depression: Evidences and personal experience.The relationship between single nucleotide polymorphisms in 5-HT2A signal transduction-related genes and the response efficacy to selective serotonin reuptake inhibitor treatments in Chinese patients with major depressive disorderEfficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.Predictors of lithium response in bipolar disorder.A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression.Augmentation treatment in major depressive disorder: focus on aripiprazoleStrategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms.How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.Add-on lithium for the treatment of unipolar depression: too often forgotten?No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients.Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology.Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression.Challenging the Negative Perception of Lithium and Optimizing Its Long-Term Administration
P2860
Q24626017-2C534376-91AD-4145-94C6-A23B8F0AB91FQ27022958-44E2FEF5-8AE2-4865-9A96-7683454A1DF7Q28081249-3D0BFA2C-6B90-477F-94E7-E657C548FD1CQ28305100-FB9A178E-DA4C-4C31-8BBC-CACECF17F6C6Q28478124-16D70372-6708-4E09-9E4E-8487FCDF84A8Q33645634-F5700FB0-BD2C-4C08-92FB-E2F4AFE81C03Q33716723-A1033D42-7ECC-4494-957E-020E90BA39F0Q33724051-E14698BC-5EF0-486A-BC4B-D609FF317119Q33920910-AD5503CD-1934-42D5-9441-9CD86A2BC2CFQ34658428-698FF11A-1555-4AE2-9554-A94B96B231E3Q35006371-31DFE2BB-33A0-4CC7-803E-B6393EE19A81Q35061175-404D2FAA-8E2D-460E-ACED-C3CEE242F54CQ35105942-EDECDE73-1A16-4448-B6F9-4C06AB515FD2Q36091234-4D4BDC88-42C5-4D2F-8D96-A42F54E45789Q36092745-644BCA6A-B3DF-4332-BF6A-3287B57A74E1Q36403127-6995D6B4-03B1-4ACB-8B76-AC2B933AAF80Q36443736-0F6303F5-62DB-4BE3-86CE-FDFADB261560Q36908442-0160CDC3-B91E-4681-A04A-7BD6E51DAE6DQ37062552-98E09239-F004-4848-AE64-5EFD3ED5D700Q37289129-42315C4B-DDB6-4CDB-BD95-A3B8E82B66C7Q41595348-FF7461F8-2466-4DC0-992B-19FA1B0F1126Q41645505-D82993A7-CB97-4B81-8C69-C05F7099EBFBQ41843348-C832DD56-9A5B-4888-8CC6-197783B411D9Q42122450-FB3F305F-FB27-4778-8395-C5AC64C475C7Q47163630-725F074A-A899-4AEA-95DD-7B452668E2FDQ47285494-AAC61AE5-51A4-4690-875C-CA278D66786BQ58586710-A99B7495-CA93-4B48-9021-D80897EA506A
P2860
Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Acceleration and augmentation ...... ed, placebo-controlled trials.
@ast
Acceleration and augmentation ...... ed, placebo-controlled trials.
@en
Acceleration and augmentation ...... ed, placebo-controlled trials.
@nl
type
label
Acceleration and augmentation ...... ed, placebo-controlled trials.
@ast
Acceleration and augmentation ...... ed, placebo-controlled trials.
@en
Acceleration and augmentation ...... ed, placebo-controlled trials.
@nl
prefLabel
Acceleration and augmentation ...... ed, placebo-controlled trials.
@ast
Acceleration and augmentation ...... ed, placebo-controlled trials.
@en
Acceleration and augmentation ...... ed, placebo-controlled trials.
@nl
P356
P1476
Acceleration and augmentation ...... zed, placebo-controlled trials
@en
P2093
Michael Bauer
Nicolas Andres Crossley
P304
P356
10.4088/JCP.V68N0617
P577
2007-06-01T00:00:00Z